295 related articles for article (PubMed ID: 17388944)
1. Proteomic identification of novel proteins in cortical lewy bodies.
Leverenz JB; Umar I; Wang Q; Montine TJ; McMillan PJ; Tsuang DW; Jin J; Pan C; Shin J; Zhu D; Zhang J
Brain Pathol; 2007 Apr; 17(2):139-45. PubMed ID: 17388944
[TBL] [Abstract][Full Text] [Related]
2. Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies.
Schlossmacher MG; Frosch MP; Gai WP; Medina M; Sharma N; Forno L; Ochiishi T; Shimura H; Sharon R; Hattori N; Langston JW; Mizuno Y; Hyman BT; Selkoe DJ; Kosik KS
Am J Pathol; 2002 May; 160(5):1655-67. PubMed ID: 12000718
[TBL] [Abstract][Full Text] [Related]
3. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M
Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110
[TBL] [Abstract][Full Text] [Related]
4. LRP10 interacts with SORL1 in the intracellular vesicle trafficking pathway in non-neuronal brain cells and localises to Lewy bodies in Parkinson's disease and dementia with Lewy bodies.
Grochowska MM; Carreras Mascaro A; Boumeester V; Natale D; Breedveld GJ; Geut H; van Cappellen WA; Boon AJW; Kievit AJA; Sammler E; ; Parchi P; Cortelli P; Alessi DR; van de Berg WDJ; Bonifati V; Mandemakers W
Acta Neuropathol; 2021 Jul; 142(1):117-137. PubMed ID: 33913039
[TBL] [Abstract][Full Text] [Related]
5. TIGAR inclusion pathology is specific for Lewy body diseases.
López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR
Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647
[TBL] [Abstract][Full Text] [Related]
6. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
[TBL] [Abstract][Full Text] [Related]
7. Colocalization of tau and alpha-synuclein epitopes in Lewy bodies.
Ishizawa T; Mattila P; Davies P; Wang D; Dickson DW
J Neuropathol Exp Neurol; 2003 Apr; 62(4):389-97. PubMed ID: 12722831
[TBL] [Abstract][Full Text] [Related]
8. Clinical and neuropathological correlates of Lewy body disease.
Hishikawa N; Hashizume Y; Yoshida M; Sobue G
Acta Neuropathol; 2003 Apr; 105(4):341-50. PubMed ID: 12624787
[TBL] [Abstract][Full Text] [Related]
9. Formation and development of Lewy pathology: a critical update.
Jellinger KA
J Neurol; 2009 Aug; 256 Suppl 3():270-9. PubMed ID: 19711116
[TBL] [Abstract][Full Text] [Related]
10. Lewy body-related alpha-synucleinopathy in aging.
Saito Y; Ruberu NN; Sawabe M; Arai T; Kazama H; Hosoi T; Yamanouchi H; Murayama S
J Neuropathol Exp Neurol; 2004 Jul; 63(7):742-9. PubMed ID: 15290899
[TBL] [Abstract][Full Text] [Related]
11. Activated microglial cells and complement factors are unrelated to cortical Lewy bodies.
Rozemuller AJ; Eikelenboom P; Theeuwes JW; Jansen Steur EN; de Vos RA
Acta Neuropathol; 2000 Dec; 100(6):701-8. PubMed ID: 11078223
[TBL] [Abstract][Full Text] [Related]
12. The brainstem pathologies of Parkinson's disease and dementia with Lewy bodies.
Seidel K; Mahlke J; Siswanto S; Krüger R; Heinsen H; Auburger G; Bouzrou M; Grinberg LT; Wicht H; Korf HW; den Dunnen W; Rüb U
Brain Pathol; 2015 Mar; 25(2):121-35. PubMed ID: 24995389
[TBL] [Abstract][Full Text] [Related]
13. Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson's disease.
Jin J; Meredith GE; Chen L; Zhou Y; Xu J; Shie FS; Lockhart P; Zhang J
Brain Res Mol Brain Res; 2005 Mar; 134(1):119-38. PubMed ID: 15790536
[TBL] [Abstract][Full Text] [Related]
14. Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease.
Mattila PM; Rinne JO; Helenius H; Dickson DW; Röyttä M
Acta Neuropathol; 2000 Sep; 100(3):285-90. PubMed ID: 10965798
[TBL] [Abstract][Full Text] [Related]
15. Abnormal localization of leucine-rich repeat kinase 2 to the endosomal-lysosomal compartment in lewy body disease.
Higashi S; Moore DJ; Yamamoto R; Minegishi M; Sato K; Togo T; Katsuse O; Uchikado H; Furukawa Y; Hino H; Kosaka K; Emson PC; Wada K; Dawson VL; Dawson TM; Arai H; Iseki E
J Neuropathol Exp Neurol; 2009 Sep; 68(9):994-1005. PubMed ID: 19680143
[TBL] [Abstract][Full Text] [Related]
16. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].
Iwatsubo T
Rinsho Shinkeigaku; 1999 Dec; 39(12):1285-6. PubMed ID: 10791099
[TBL] [Abstract][Full Text] [Related]
17. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.
Baba M; Nakajo S; Tu PH; Tomita T; Nakaya K; Lee VM; Trojanowski JQ; Iwatsubo T
Am J Pathol; 1998 Apr; 152(4):879-84. PubMed ID: 9546347
[TBL] [Abstract][Full Text] [Related]
18. Immunoreactivity of myelin-associated oligodendrocytic basic protein in Lewy bodies.
Kon T; Tanji K; Mori F; Kimura A; Kakita A; Wakabayashi K
Neuropathology; 2019 Aug; 39(4):279-285. PubMed ID: 31183926
[TBL] [Abstract][Full Text] [Related]
19. An order in Lewy body disorders: Retrograde degeneration in hyperbranching axons as a fundamental structural template accounting for focal/multifocal Lewy body disease.
Uchihara T
Neuropathology; 2017 Apr; 37(2):129-149. PubMed ID: 27862327
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy body disease.
Iwatsubo T; Yamaguchi H; Fujimuro M; Yokosawa H; Ihara Y; Trojanowski JQ; Lee VM
Am J Pathol; 1996 May; 148(5):1517-29. PubMed ID: 8623921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
